Your browser doesn't support javascript.
loading
ELTD1 deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma.
Huang, Hua; Georganaki, Maria; Conze, Lei Liu; Laviña, Bàrbara; van Hooren, Luuk; Vemuri, Kalyani; van de Walle, Tiarne; Ramachandran, Mohanraj; Zhang, Lei; Pontén, Fredrik; Bergqvist, Michael; Smits, Anja; Betsholtz, Christer; Dejana, Elisabetta; Magnusson, Peetra U; He, Liqun; Lugano, Roberta; Dimberg, Anna.
Affiliation
  • Huang H; Department of Immunology, Genetics and Pathology, The Rudbeck Laboratory, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Georganaki M; Department of Immunology, Genetics and Pathology, The Rudbeck Laboratory, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Conze LL; Department of Immunology, Genetics and Pathology, The Rudbeck Laboratory, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Laviña B; Department of Immunology, Genetics and Pathology, The Rudbeck Laboratory, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • van Hooren L; Department of Immunology, Genetics and Pathology, The Rudbeck Laboratory, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Vemuri K; Department of Immunology, Genetics and Pathology, The Rudbeck Laboratory, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • van de Walle T; Department of Immunology, Genetics and Pathology, The Rudbeck Laboratory, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Ramachandran M; Department of Immunology, Genetics and Pathology, The Rudbeck Laboratory, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Zhang L; Key Laboratory of Ministry of Education for Medicinal Plant Resource and Natural Pharmaceutical Chemistry, National Engineering Laboratory for Resource Developing of Endangered Chinese Crude Drugs in Northwest of China, College of Life Sciences, Shaanxi Normal University, Xi'an, China.
  • Pontén F; Department of Immunology, Genetics and Pathology, The Rudbeck Laboratory, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Bergqvist M; Center for Research and Development, Gävle Hospital, Uppsala University, Gävle, Sweden.
  • Smits A; Department of Radiation Sciences and Oncology, Umeå University Hospital, Umeå, Sweden.
  • Betsholtz C; Department of Clinical Neuroscience, Sahlgrenska Academy, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden.
  • Dejana E; Department of Immunology, Genetics and Pathology, The Rudbeck Laboratory, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Magnusson PU; Department of Immunology, Genetics and Pathology, The Rudbeck Laboratory, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • He L; Department of Immunology, Genetics and Pathology, The Rudbeck Laboratory, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Lugano R; Department of Immunology, Genetics and Pathology, The Rudbeck Laboratory, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Dimberg A; Department of Immunology, Genetics and Pathology, The Rudbeck Laboratory, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Neuro Oncol ; 24(3): 398-411, 2022 03 12.
Article in En | MEDLINE | ID: mdl-34347079

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Receptors, G-Protein-Coupled / Glioma Limits: Animals / Humans Language: En Journal: Neuro Oncol Journal subject: NEOPLASIAS / NEUROLOGIA Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Receptors, G-Protein-Coupled / Glioma Limits: Animals / Humans Language: En Journal: Neuro Oncol Journal subject: NEOPLASIAS / NEUROLOGIA Year: 2022 Document type: Article Affiliation country: Country of publication: